Cilostazol for secondary stroke prevention: systematic review and meta-analysis.

Stroke Vasc Neurol · 2021 · PMC8485237 · PMID 33542092

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

just missed significanceno p-value reported

Compared with aspirin monotherapy, the risk reduction of cilostazol DAPT was greater but just missed significance; we were not able to comment on its efficacy against clopidogrel monotherapy as it was compared with clopidogrel monotherapy in only one trial. 38 In contrast to ASA+CLO combination therapy whose use is typically limited to 3 months or less, 40 our results suggest that cilostazol combination therap

also in 165 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.